MedTrace Logo

Randomized Controlled Trial of Tailored Interactive Multimedia to Reduce Colorectal Cancer Screening Disparities

NCT00786747 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1164

Last updated 2015-12-03

No results posted yet for this study

Summary

The study investigators have developed an interactive multimedia computer program that provides personally tailored education about colorectal cancer screening in the user's preferred language (English or Spanish). In this study, the investigators will examine whether use of the computer program increases the number of Hispanic patients who receive colorectal cancer screening and lessens or eliminates the glaring disparity in screening between Hispanics and non-Hispanic whites.

Conditions

  • Colorectal Neoplasms

Interventions

BEHAVIORAL

Personally tailored computer program

The experimental computer program provides the user with information about colorectal cancer screening that is tailored to their self-efficacy, readiness, and perceived barriers to undergoing screening, in their preferred language (English or Spanish).

BEHAVIORAL

Non-tailored control computer program

This program provides users with non-tailored information about colorectal cancer screening, in their preferred language (English or Spanish).

Sponsors & Collaborators

  • University of Rochester

    collaborator OTHER

  • City University of New York, School of Public Health

    collaborator OTHER

  • University of California, Davis

    lead OTHER

Principal Investigators

  • Anthony Jerant, MD · University of California, Davis

Study Design

Allocation
RANDOMIZED
Purpose
SCREENING
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
50 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-02-28
Primary Completion
2011-10-31
Completion
2012-11-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00786747 on ClinicalTrials.gov